Octavia Bane, Erdmann Seeliger, Eleanor Cox, Julia Stabinska, Eric Bechler, Sara Lewis, LaTonya J Hickson, Sue Francis, Eric Sigmund, Thoralf Niendorf
Renal diseases pose a significant socio-economic burden on healthcare systems. The development of better diagnostics and prognostics is well-recognized as a key strategy to resolve these challenges. Central to these developments are MRI biomarkers, due to their potential for monitoring of early pathophysiological changes, renal disease progression or treatment effects. The surge in renal MRI involves major cross-domain initiatives, large clinical studies, and educational programs. In parallel with these translational efforts, the need for greater (patho)physiological specificity remains, to enable engagement with clinical nephrologists and increase the associated health impact...
May 26, 2023: Journal of Magnetic Resonance Imaging: JMRI